Insiders MaxCyte, Inc.

Equities

Market Closed - London S.E. Other stock markets 16:35:02 15/05/2024 BST			5-day change	1st Jan Change
370 ^GBX	-2.12%		-6.33%	+4.96%

05-08	MaxCyte Shares Rise Sharply After Q1 Results Beat	MT
05-08	MaxCyte shares rise amid double-digit revenue increase	AN

MaxCyte inks deal with Be Bio; Orcadian firms farmout	04-02	AN
MaxCyte chief scientific officer leaves firm	01-29	AN
MaxCyte, Inc. Announces Departure of Cenk Sumen as Chief Scientific Officer	01-26	CI
MaxCyte's New President/CEO Takes Office	01-02	MT
Technology Minerals identifies lithium at Knockeen	12-12	AN
MaxCyte President/CEO to Step Down; Successor Appointed	12-12	MT
MaxCyte Names New Chief Executive	12-12	MT
MaxCyte, Inc Announces Executive Changes	12-11	CI
MaxCyte, Inc Announces Executive Changes	12-11	CI
Maxcyte Insider Sold Shares Worth $639,405, According to a Recent SEC Filing	12-06	MT
Maxcyte, Inc. Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing	06/09/23	CI
Insider Sell: Maxcyte	15/06/23	MT
MaxCyte Chair Richard Douglas buys USD350,000 in shares	30/03/23	AN
Insider Buy: Maxcyte	30/03/23	MT
MaxCyte appoints new chief financial officer, effective immediately	28/03/23	AN
Cell Engineering Company MaxCyte Appoints New CFO	28/03/23	MT
MaxCyte Names Douglas Swirsky CFO	27/03/23	MT
MaxCyte, Inc. Appoints Ron Holtz as EVP, Administration	27/03/23	CI
MaxCyte, Inc. Appoints Douglas J. Swirsky as Chief Financial Officer	27/03/23	CI
MaxCyte names members of new scientific advisory board	08/03/23	AN

No results for this search